Nkọwa zuru ezu
Chlamydia pneumoniae (C. pneumoniae) bụ ụdị nje bacteria na-emekarị na ihe bụ isi na-akpata oyi baa gburugburu ụwa.Ihe dị ka 50% nke ndị toro eto nwere ihe akaebe nke ọrịa gara aga site na afọ 20, na ịmaliteghachi n'oge ndụ na-adịkarị.Ọtụtụ nnyocha egosiwo njikọ kpọmkwem n'etiti ọrịa C. pneumoniae na ọrịa ndị ọzọ na-egbuke egbuke dị ka atherosclerosis, nnukwu exacerbations nke COPD, na ụkwara ume ọkụ.Nchọpụta nke ọrịa C. pneumoniae bụ ihe ịma aka n'ihi ọdịdị ngwa ngwa nke nje na-akpata, nnukwu seroprevalence, na ohere nke ụgbọ ala asymptomatic na-agafe agafe.Ụzọ ụlọ nyocha achọpụtara nke ọma gụnyere ikewapụ akụkụ ahụ na omenala cell, nyocha serological na PCR.Nnwale Microimmunofluorescence (MIF), bụ “ọkọlọtọ ọla edo” dị ugbu a maka nyocha serological, mana nyocha ahụ ka enweghị nhazi yana ọ na-esiri ike teknụzụ.Immunoassay nke mgbochi bụ ule serology a na-ejikarị eme ihe yana ọrịa chlamydial bụ isi bụ nzaghachi IgM kachasị n'ime izu 2 ruo 4 yana nzaghachi IgG na IgA na-egbu oge n'ime izu 6 ruo 8.Otú ọ dị, na nlọghachi azụ, ọkwa IgG na IgA na-ebili ngwa ngwa, mgbe mgbe n'ime izu 1-2 ebe a na-adịkarịghị achọpụta ọkwa IgM.N'ihi nke a, ọgwụ mgbochi IgA egosila na ọ bụ akara immunological nke a pụrụ ịdabere na ya nke isi, ọrịa na-adịghị ala ala na nke na-emekarị mgbe ọ na-ejikọta ya na nchọpụta IgM.